INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$100
10.0K sh
Jun 22, 2026Jun 29, 2026
Page 198 of 481
← PrevNext →

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELL
traded Jun 22, 2026
+7d
SEC Form 4

Evidence

33
BB
Baggio BarbaraWIFE OF CEO
VPLMVoip-pal.com Inc
Open-market sale
SELL$150
15.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$794K
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

33
BB
Baggio BarbaraWIFE OF CEO
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,468
235.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

33
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,400
240.0K sh
Jun 22, 2026Jun 29, 2026
traded Jun 22, 2026
+7dSEC Form 4

Evidence

29
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$298K
14.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

25
HY
Huang YingDirector, Chief Executive Officer
LEGNLegend Biotech Corp
Open-market sale
SELL$82K
5,566 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

24
GE
Giles Bryan ECHIEF FINANCIAL OFFICER
AVOMission Produce, Inc.
Open-market sale
SELL$61K
5,000 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

23
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$387K
7,878 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

20
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$250K
2,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$70K
211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$67K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
BS
Bobulsky SusanChief Commercial Officer, MRD
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$103K
5,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$106K
331 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$186K
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$104K
18.1K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$33K
100 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$298K
11.4K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

14
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$66K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$7,826
1,373 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
11.5K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
DA
Doudna Jennifer ADirector
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
2,673 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$63K
500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

8
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$76K
1,500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$36K
110 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$49K
150 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$26K
79 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,200 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

4
DS
Dhanasekaran SatishDirector, President and CEO
KEYSKeysight Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$183K
507 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

4
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$167K
33.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

1
RN
Rosenberg NickExecutive Vice President
MCBMetropolitan Bank Holding Corp.
Open-market sale · 10b5-1 plan
SELL$9,005
90 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

1
RN
Rosenberg NickExecutive Vice President
MCBMetropolitan Bank Holding Corp.
Open-market sale · 10b5-1 plan
SELL$26K
263 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

1
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$500
100 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

48
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Open-market sale
SELL$432K
1,860 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

42
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$563K
14.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

42
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$1.27M
33.3K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

42
VC
Van Tuyl ChristopherChief Legal Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$572K
15.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 16
7 insiders$7.38M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K